# Post-Ibrutinib Colitis and Intestinal Microbiota

> **NCT03569137** · — · UNKNOWN · sponsor: **Nantes University Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Gastrointestinal Microbiome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03569137
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2019-08-01
- **Final completion:** 2020-08-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03569137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03569137, "Post-Ibrutinib Colitis and Intestinal Microbiota". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03569137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*